A new study published in Aging Cell demonstrates that artificial intelligence can be used not just to accelerate drug ...

An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

IO Biotech was named to Fast Company’s World’s Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...

CAST, groups fine details into object-level concepts as attention moves from lower to high layers, outputting a ...

Data presented at American Association for Cancer Research (AACR) Annual Meeting. In April 2025, Foghorn presented new preclinical data highlighting pipeline progress for potential first-in-class ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

Inflammation peptides have emerged as intriguing molecules in scientific exploration, offering various properties that may hold promise for diverse research domains.

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

The company stated that it has installed 37 systems, which have been used in over 750 multi-specialty surgeries.